Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;30(12):6402-6412.
doi: 10.1007/s00330-020-07004-3. Epub 2020 Jul 1.

Characterization of parotid gland tumors: added value of permeability MR imaging to DWI and DCE-MRI

Affiliations

Characterization of parotid gland tumors: added value of permeability MR imaging to DWI and DCE-MRI

Hidetake Yabuuchi et al. Eur Radiol. 2020 Dec.

Abstract

Objectives: To determine added value of permeability MRI in parotid tumor characterization to T2-weighted imaging (T2WI), semi-quantitative analysis of time-intensity curve (TIC), and intra-voxel incoherent motion diffusion-weighted imaging (IVIM-DWI).

Methods: This retrospective study was approved by the institutional review board, and the informed consent was waived. Sixty-one parotid tumors in 61 patients were examined using T2WI, IVIM-DWI, and permeability MRI. TIC patterns were categorized as persistent, washout, or plateau. Signal intensity ratio of lesion-to-muscle on T2WI, apparent diffusion coefficients (ADCs), D and f values from IVIM-DWI, and Ktrans, kep, Ve, and Vp values from permeability MRI were measured. Multiple comparisons were applied to determine whether any differences among 4 histopathologic types (pleomorphic adenomas, Warthin's tumors, other benign tumors, and malignant tumors) existed. Diagnostic accuracy was compared before and after modification diagnosis referring to permeability MRI. In a validation study, 60 parotid tumors in 60 patients were examined.

Results: ADC and D values of malignant tumors were significantly lower than those of benign tumors other than Warthin's tumors, but higher than those of Warthin's tumors. kep and Vp values of Warthin's tumors were significantly higher than those of malignant tumors. Multivariate analyses showed that TIC pattern, D, and kep values were suitable parameters. McNemar's test showed a significant increase of sensitivity (11/12, 92%) and specificity (46/49, 94%) with adding kep. The validation study yielded high sensitivity (14/16, 88%) and specificity (41/44, 93%).

Conclusion: Permeability MRI offers added value to IVIM-MRI and semi-quantitative TIC analysis of DCE-MRI in characterization of parotid tumors KEY POINTS: • Permeability MR imaging offers added value in the characterization of parotid gland tumors in combination with semi-quantitative TIC analysis and IVIM analyses with D parameter. • The combination of TIC pattern, D, and kep might facilitate accurate characterization of parotid gland tumor, thereby avoiding unnecessary surgery for benign tumors or delayed treatment for malignant tumors. • A combination of permeability and diffusion MR imaging can be used to guide the selection of an appropriate biopsy site.

Keywords: Diffusion; Magnetic resonance imaging; Neoplasms; Parotid gland; Perfusion.

PubMed Disclaimer

References

    1. Guzzo M, Locati LD, Prott FJ, Gatta G, McGurk M, Licitra L (2010) Major and minor salivary gland tumors. Crit Rev Oncol Hematol 74:134–148 - DOI - PMC
    1. Spiro RH (1986) Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 8:177–184 - DOI - PMC
    1. Larian B (2016) Parotidectomy for benign parotid tumors. Otolaryngol Clin North Am 49:395–413 - DOI
    1. Dell'Aversana Orabona G, Bonavolontà P, Iaconetta G, Forte R, Califano L (2013) Surgical management of benign tumors of the parotid gland: extracapsular dissection versus superficial parotidectomy-our experience in 232 cases. J Oral Maxillofac Surg 71:410–413 - DOI
    1. Lim YC, Lee SY, Kim K et al (2005) Conservative parotidectomy for the treatment of parotid cancers. Oral Oncol 41:1021–1027 - DOI

MeSH terms

LinkOut - more resources